Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
01 1AARTI PHARMALABS LIMITED Mulund (W), Mumbai IN
01 1Salmeterol xinafoate
01 1India
01 1Valid
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
Certificate Number : R1-CEP 2008-239 - Rev 04
Status : Valid
Issue Date : 2022-10-14
Type : Chemical
Substance Number : 1765
20
Aarti Pharmalabs Limited Mulund (w), Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
One of their significant offerings is Salmeterol xinafoate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2008-239 - Rev 04
This Chemical Type CEP, issued on October 14, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1765 associated with this CEP further emphasizes
LOOKING FOR A SUPPLIER?